The treatment of anti-NMDAR encephalitis involves immunotherapy, tumor diagnosis, and excision. Early immunotherapy has shown to improve outcomes. Treatment options include corticosteroids, plasmapheresis, immunoglobulins, and rituximab.

The treatment of anti-NMDAR encephalitis should include immunotherapy and the diagnosis and excision of the tumor.  There is evidence that early immunotherapy may result in quicker recovery and decreased mortality.

Current immunotherapy includes corticosteroids, immune plasmapheresis, intravenous immunoglobulins, and rituximab.

^{[1] [2]}